Der Pathologe

, Volume 38, Issue 6, pp 507–514 | Cite as

Retinoblastom und Retinozytom (Retinom)

  • K. A. Metz
  • D. Westerwick
  • F. Driever
  • K. W. Schmid
  • C. H. D. Le Guin
Schwerpunkt: Tumoren der Sinnesorgane
  • 158 Downloads

Zusammenfassung

Retinoblastome sind außerordentlich seltene, in ca. der Hälfte der Fälle erbliche frühkindliche Augenneoplasien. Sie zeigen hochproliferative, CRX-positive („cone-rod homeobox protein“) undifferenzierte Tumorzellen (z. T. auch mit Rosettenbildung). Das Staging richtet sich nach der pTNM-Klassifikation und dem „International Retinoblastoma Staging System“ (IRSS). Die Grundlage für eine eventuelle systemische Chemotherapie und/oder Radiatio ist der Nachweis einer postlaminären Optikusinfiltration, ausgeprägten Choroideainfiltration, Sklerainvasion oder sogar extraokulärer Ausbreitung. In morphologisch schwierigen Fällen sind immunhistochemische Untersuchungen (CRX und Ki67) äußerst hilfreich. Retinozytome (Retinome) zeigen keine undifferenzierten Tumorareale, sondern ausschließlich eine Photorezeptordifferenzierung sowie eine mittels Ki67 nachgewiesene auffallend geringe Proliferation.

Schlüsselwörter

Immunhistochemie Augenneoplasie Leukokorie Immunhistochemie Choroideainfiltration 

Retinoblastoma and retinocytoma (retinoma)

Abstract

Retinoblastomas are extremely rare withabout half of the cases being hereditary eye neoplasms in young children. They show highly proliferative, CRX-positive undifferentiated tumour cells (occasionally forming rosettes). Staging is performed according to the pTNM classification and the International Retinoblastoma Staging System (IRSS). The diagnostic basis for systemic administration of chemotherapy and/or radiation is postlaminar optic nerve invasion, massive choroidal tumour infiltration, scleral invasion or even extraocular invasion. In cases that are difficult to diagnose, immunohistochemical stains (CRX and Ki67) may be very helpful. Retinocytomas (retinomas) completely lack undifferentiated tumour cell areas, show an exclusive photoreceptor differentiation and an exceptionally low Ki67 index.

Keywords

Immunohistochemistry Eye neoplasm Leukocoria Immunohistochemistry Choroid infiltration 

Notes

Einhaltung ethischer Richtlinien

Interessenkonflikt

K. . Metz, D. Westerwick, F. Driever, K.W. Schmid und C.H.D. Le Guin geben an, dass kein Interessenkonflikt besteht.

Dieser Beitrag beinhaltet keine von den Autoren durchgeführten Studien an Menschen oder Tieren.

Literatur

  1. 1.
    Abouzeid H, Balmer A, Moulin AP et al (2012) Phenotypic variability of retinocytomas: preregression and postregression growth patterns. Br J Ophthalmol 96:884–889CrossRefPubMedGoogle Scholar
  2. 2.
    Brierley J, Gospodarowicz MK, Wittekind C (2017) TNM classification of malignant tumours. Wiley, ChichesterGoogle Scholar
  3. 3.
    Chantada G, Doz F, Antoneli CB et al (2006) A proposal for an international retinoblastoma staging system. Pediatr Blood Cancer 47:801–805CrossRefPubMedGoogle Scholar
  4. 4.
    Dimaras H, Khetan V, Halliday W et al (2008) Loss of RB1 induces non-proliferative retinoma: increasing genomic instability correlates with progression to retinoblastoma. Hum Mol Genet 17:1363–1372CrossRefPubMedGoogle Scholar
  5. 5.
    Flexner S (1891) A peculiar glioma (neuroepithelioma?) of the retina. Johns Hopkins Hosp Bull 2:115–119Google Scholar
  6. 6.
    Francis JH, Brodie SE, Marr B et al (2017) Efficacy and toxicity of intravitreous chemotherapy for retinoblastoma: four-year experience. Ophthalmology 124:488–495CrossRefPubMedGoogle Scholar
  7. 7.
    Gallie BL, Ellsworth RM, Abramson DH et al (1982) Retinoma: spontaneous regression of retinoblastoma or benign manifestation of the mutation? Br J Cancer 45:513–521CrossRefPubMedPubMedCentralGoogle Scholar
  8. 8.
    Graefe AV (1868) Zusätze über intraoculare Tumoren. Arch Ophthalmol 14:103–144Google Scholar
  9. 9.
    Kivela T (1999) Trilateral retinoblastoma: a meta-analysis of hereditary retinoblastoma associated with primary ectopic intracranial retinoblastoma. J Clin Oncol 17:1829–1837CrossRefPubMedGoogle Scholar
  10. 10.
    Kivela T, Polkunen ML (2003) Pieter Pauw’s tumor oculorum: reappraisal of the presumed first description of retinoblastoma in 1597. Arch Ophthalmol 121:881–886CrossRefPubMedGoogle Scholar
  11. 11.
    Knudson AG Jr. (1971) Mutation and cancer: statistical study of retinoblastoma. Proc Natl Acad Sci USA 68:820–823CrossRefPubMedPubMedCentralGoogle Scholar
  12. 12.
    Lee WH, Bookstein R, Hong F et al (1987) Human retinoblastoma susceptibility gene: cloning, identification, and sequence. Science 235:1394–1399CrossRefPubMedGoogle Scholar
  13. 13.
    Liu Y, Zhong X, Wan S et al (2014) p16(INK4a) expression in retinoblastoma: a marker of differentiation grade. Diagn Pathol 9:180CrossRefPubMedPubMedCentralGoogle Scholar
  14. 14.
    Lohmann DR (1999) RB1 gene mutations in retinoblastoma. Hum Mutat 14:283–288CrossRefPubMedGoogle Scholar
  15. 15.
    Lohmann DR, Brandt B, Hopping W et al (1996) The spectrum of RB1 germ-line mutations in hereditary retinoblastoma. Am J Hum Genet 58:940–949PubMedPubMedCentralGoogle Scholar
  16. 16.
    Lohmann DR, Brandt B, Passarge E et al (1997) Molekulare Genetik und Diagnostik des Retinoblastoms. Bedeutung für die Ophthalmologische Praxis. Ophthalmologe 94:263–267CrossRefPubMedGoogle Scholar
  17. 17.
    Maccarthy A, Draper GJ, Steliarova-Foucher E et al (2006) Retinoblastoma incidence and survival in European children (1978–1997). Report from the Automated Childhood Cancer Information System project. Eur J Cancer 42:2092–2102CrossRefPubMedGoogle Scholar
  18. 18.
    Margo C, Hidayat A, Kopelman J et al (1983) Retinocytoma. A benign variant of retinoblastoma. Arch Ophthalmol 101:1519–1531CrossRefPubMedGoogle Scholar
  19. 19.
    Mendoza PR, Specht CS, Hubbard GB et al (2015) Histopathologic grading of anaplasia in retinoblastoma. Am J Ophthalmol 159:764–776CrossRefPubMedGoogle Scholar
  20. 20.
    Santagata S, Maire CL, Idbaih A et al (2009) CRX is a diagnostic marker of retinal and pineal lineage tumors. PLoS ONE 4:e7932CrossRefPubMedPubMedCentralGoogle Scholar
  21. 21.
    Schedler KJ, Traine PG, Lohmann DR et al (2016) Hereditary diffuse infiltrating retinoblastoma. Ophthalmic Genet 37:95–97PubMedGoogle Scholar
  22. 22.
    Schofield PB (1960) Diffuse infiltrating retinoblastoma. Br J Ophthalmol 44:35–41CrossRefPubMedPubMedCentralGoogle Scholar
  23. 23.
    Sengupta S, Pan U, Khetan V (2016) Adult onset retinoblastoma. Indian J Ophthalmol 64:485–491CrossRefPubMedPubMedCentralGoogle Scholar
  24. 24.
    Shields CL, Alset AE, Say EA et al (2016) Retinoblastoma control with primary intra-arterial chemotherapy: outcomes before and during the intravitreal chemotherapy era. J Pediatr Ophthalmol Strabismus 53:275–284CrossRefPubMedGoogle Scholar
  25. 25.
    Shields CL, Ghassemi F, Tuncer S et al (2008) Clinical spectrum of diffuse infiltrating retinoblastoma in 34 consecutive eyes. Ophthalmology 115:2253–2258CrossRefPubMedGoogle Scholar
  26. 26.
    Shields CL, Mashayekhi A, Au AK et al (2006) The international classification of retinoblastoma predicts chemoreduction success. Ophthalmology 113:2276–2280CrossRefPubMedGoogle Scholar
  27. 27.
    Shields CL, Schoenberg E, Kocher K et al (2013) Lesions simulating retinoblastoma (pseudoretinoblastoma) in 604 cases: results based on age at presentation. Ophthalmology 120:311–316CrossRefPubMedGoogle Scholar
  28. 28.
    Temming P, Arendt M, Viehmann A et al (2017) Incidence of second cancers after radiotherapy and systemic chemotherapy in heritable retinoblastoma survivors: a report from the German reference center. Pediatr Blood Cancer 64:71–80CrossRefPubMedGoogle Scholar
  29. 29.
    Temming P, Lohmann D, Bornfeld N et al (2012) Current concepts for diagnosis and treatment of retinoblastoma in Germany: aiming for safe tumor control and vision preservation. Klin Padiatr 224:339–347CrossRefPubMedGoogle Scholar
  30. 30.
    Traine PG, Schedler KJ, Rodrigues EB (2016) Clinical presentation and genetic paradigm of diffuse infiltrating retinoblastoma: a review. Ocul Oncol Pathol 2:128–132CrossRefPubMedGoogle Scholar
  31. 31.
    Ts’o MO, Zimmerman LE, Fine BS (1970) The nature of retinoblastoma. I. Photoreceptor differentiation: a clinical and histopathologic study. Am J Ophthalmol 69:339–349CrossRefPubMedGoogle Scholar
  32. 32.
    Verhoeff F, Jackson E (1926) Minutes of the proceedings, 62nd annual meeting. Trans Am Ophthalmol Soc 24:38–43Google Scholar
  33. 33.
    Wardrop J (1809) Observations on fungus hæmatodes or soft cancer, in several of the most important organs of the human body: containing also a comparative view of the structure of fungus hæmatodes and cancer. With cases and dissections. Constable, EdinburghGoogle Scholar
  34. 34.
    Wintersteiner H (1897) Die zellen der geschwulst. In: Das neuroepithelioma retinae: Eine anatomische und klinische studie. Leipzig: Franz Deuticke, S 12–16Google Scholar
  35. 35.
    Wippold FJ 2nd, Perry A (2006) Neuropathology for the neuroradiologist: rosettes and pseudorosettes. AJNR Am J Neuroradiol 27:488–492PubMedGoogle Scholar

Copyright information

© Springer Medizin Verlag GmbH 2017

Authors and Affiliations

  • K. A. Metz
    • 1
  • D. Westerwick
    • 1
  • F. Driever
    • 1
  • K. W. Schmid
    • 1
  • C. H. D. Le Guin
    • 2
  1. 1.Institut für PathologieUniversitätsklinikum Essen, Universität Duisburg-EssenEssenDeutschland
  2. 2.Klinik für AugenheilkundeUniversitätsklinikum Essen, Universität Duisburg-EssenEssenDeutschland

Personalised recommendations